Royal Sense P/B Ratio
Current P/B Ratio
2.42
Moderate Valuation
High - Premium to book value, growth expectations or asset-light model
Royal Sense (ROYAL) P/B ratio is 2.42 (Moderate), book value per share ₹56.00 vs Healthcare average P/B of -0.94 — High - Premium to book value, growth expectations or asset-light model. View Royal Sense yearly highs lows for the annual high/low range and current price position.
Current Valuation Metrics
P/B Ratio
2.42
Current Price
₹
Book Value/Share
₹56.00
Exchange
None
Book Value Breakdown (2025)
Balance Sheet Components
Total Equity
₹28 Cr
Share Capital
₹5 Cr
Reserves & Surplus
₹21 Cr
Outstanding Shares
5,000,000
Book Value per Share
₹56.00
Valuation Signal
Signal
Fairly Valued
Sector Context
Sector Average
-0.94
Sector Median
0.6
Sector Rank
#11 of 50
Sector Percentile
22.0%
ROYAL P/B Ratio — Valuation Insights & Book Value Analysis
Royal Sense price-to-book ratio interpretation, valuation status and historical context — current P/B 2.42 (Moderate). For live price, earnings yield and the full fundamental profile, see Royal Sense share price chart.
- Trading at premium to sector average PB of -0.94
ROYAL vs Healthcare Peers — P/B Ratio Comparison
Royal Sense P/B 2.42 vs Healthcare average -0.94, median 0.6 — range -31.21–1.03.
Sector Average
-0.94
Sector Median
0.6
Lowest P/B
-31.21
Highest P/B
1.03
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -31.21 | ₹25 | Low |
| Sun Pharma Advanced Rese… | SPARC | -16.05 | ₹5,310 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Parmax Pharma | PARMAX | -2.16 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.76 | ₹121 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |